Detalhe da pesquisa
1.
Final safety and efficacy results from a 106 real-world patients registry with an ascites-mobilizing pump.
Liver Int
; 42(10): 2247-2259, 2022 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-35686702
2.
Consensus care recommendations for alfapump® in cirrhotic patients with refractory or recurrent ascites.
BMC Gastroenterol
; 22(1): 111, 2022 Mar 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-35260086
3.
Novel pleural-bladder pump in malignant pleural effusions: from animal model to man.
Thorax
; 75(5): 432-434, 2020 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-32165417
4.
Improvement in Quality of Life and Decrease in Large-Volume Paracentesis Requirements With the Automated Low-Flow Ascites Pump.
Liver Transpl
; 26(5): 651-661, 2020 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-31999044
5.
Feasibility and Procedural Safety of alfapump System Implantation by IR: Experience from the MOSAIC Study, a Multicenter, Open-Label Prospective Study in Cirrhotic Patients with Refractory Ascites.
J Vasc Interv Radiol
; 31(8): 1256-1262.e3, 2020 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-32654961
6.
Continuous low flow ascites drainage through the urinary bladder via the Alfapump system in palliative patients with malignant ascites.
BMC Palliat Care
; 18(1): 109, 2019 Dec 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-31805921
7.
Patients with refractory ascites treated with alfapump® system have better health-related quality of life as compared to those treated with large volume paracentesis: the results of a multicenter randomized controlled study.
Qual Life Res
; 27(6): 1513-1520, 2018 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-29460201